Bath & Body Works (NYSE:BBWI) Stock Gets Price Target Trim from BMO Capital Markets

Bath & Body Works (NYSE:BBWI – Get Free Report) had its price target reduced by stock analysts at BMO Capital Markets from $24.00 to $20.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has a “market perform” rating on the stock. BMO Capital Markets‘s price objective would indicate a potential upside of 5.62% from the company’s current price.

A number of other equities research analysts have also recently weighed in on the stock. UBS Group lifted their price objective on shares of Bath & Body Works from $17.00 to $22.00 and gave the company a “neutral” rating in a research note on Friday, November 13th. Argus reiterated a “hold” rating on shares of Bath & Body Works in a research report on Wednesday, September 16th. Citigroup upgraded shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 target price for the company in a research report on Tuesday, August 18th. Morgan Stanley lowered their target price on shares of Bath & Body Works from $22.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Friday. Finally, Barclays dropped their price target on shares of Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 27th. Four research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $22.27.

Get Our Latest Analysis on Bath & Body Works

Bath & Body Works Trading Up 0.1%

BBWI traded up $0.03 during trading hours on Friday, hitting $18.93. The company’s stock had a trading volume of 1,828,155 shares, compared to its average volume of 6,023,616. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $24.94. The firm has a market capitalization of $3.82 billion, a PE ratio of 4.96, a PEG ratio of 0.93 and a beta of 1.31. The company has a 50-day simple moving average of $19.24 and a 200 day simple moving average of $19.77.

Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings results on Thursday, November 19th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.14. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter in the previous year, the firm posted $0.37 EPS. The firm’s quarterly revenue was down 1.1% on a year-over-year basis. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Research analysts expect that Bath & Body Works will post 2.74 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bath & Body Works

A number of institutional investors and hedge funds have recently bought and sold shares of BBWI. Algert Global LLC lifted its stake in Bath & Body Works by 36.0% during the third quarter. Algert Global LLC now owns 684,287 shares of the company’s stock valued at $10,894,000 after purchasing an additional 181,023 shares during the last quarter. Ancora Advisors LLC grew its position in Bath & Body Works by 107,891.7% in the third quarter. Ancora Advisors LLC now owns 12,959 shares of the company’s stock worth $206,000 after buying an additional 12,947 shares during the last quarter. Readystate Asset Management LP increased its holdings in shares of Bath & Body Works by 408.8% in the third quarter. Readystate Asset Management LP now owns 579,712 shares of the company’s stock valued at $9,229,000 after buying an additional 465,780 shares in the last quarter. Ares Systematic Credit Ltd bought a new position in shares of Bath & Body Works in the third quarter valued at $442,000. Finally, Saba Capital Management L.P. lifted its position in shares of Bath & Body Works by 784.2% during the 3rd quarter. Saba Capital Management L.P. now owns 84,111 shares of the company’s stock valued at $1,339,000 after acquiring an additional 74,598 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works News Summary

These are some of the BBWI news items that stood out recently:

  • Positive Sentiment: Third-quarter adjusted EPS was $0.26, above the $0.12 consensus, and revenue of $1.58 billion topped expectations. The company also raised its full-year sales outlook, citing progress in digital and wholesale channels. Third-quarter results and updated outlook
  • Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a new seasonal offering, though the financial impact is not yet clear. Pantone collaboration announcement
  • Negative Sentiment: The fourth-quarter EPS outlook of $1.41–$1.61 is below analysts’ $1.72 estimate, and revenue guidance also falls short of consensus at its upper end. Management warned of softer holiday sales; quarterly revenue and EPS were also below year-ago levels. This cautious near-term outlook may overshadow the earnings beat and higher full-year sales forecast. Holiday sales outlook

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.

See Also

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.